Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 18
2003 24
2004 31
2005 32
2006 36
2007 38
2008 40
2009 49
2010 69
2011 58
2012 48
2013 86
2014 60
2015 62
2016 49
2017 34
2018 26
2019 21
2020 25
2021 23
2022 29
2023 25
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

751 results

Results by year

Filters applied: . Clear all
Page 1
Can Pharmacological Conditioning as an Add-On Treatment Optimize Standard Pharmacological Treatment in Patients with Recent-Onset Rheumatoid Arthritis? A Proof-of-Principle Randomized Clinical Trial.
Manaï M, van Middendorp H, van der Pol JA, Allaart CF, Dusseldorp E, Veldhuijzen DS, Huizinga TWJ, Evers AWM. Manaï M, et al. Among authors: huizinga twj. Pharmaceuticals (Basel). 2024 Jan 13;17(1):110. doi: 10.3390/ph17010110. Pharmaceuticals (Basel). 2024. PMID: 38256943 Free PMC article.
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome.
Aguirre Del-Pino R, Monahan RC, Huizinga TWJ, Eikenboom J, Steup-Beekman GM. Aguirre Del-Pino R, et al. Among authors: huizinga twj. Semin Thromb Hemost. 2024 Jan 16. doi: 10.1055/s-0043-1776910. Online ahead of print. Semin Thromb Hemost. 2024. PMID: 38228166 Free article.
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis.
van Ouwerkerk L, Bergstra SA, Maarseveen TD, Huizinga TWJ, Knevel R, Allaart CF. van Ouwerkerk L, et al. Among authors: huizinga twj. Semin Arthritis Rheum. 2024 Feb;64:152305. doi: 10.1016/j.semarthrit.2023.152305. Epub 2023 Nov 10. Semin Arthritis Rheum. 2024. PMID: 37992515
IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis.
van Wesemael TJ, Reijm S, Kawakami A, Dorjée AL, Stoeken G, Maeda T, Kawashiri SY, Huizinga TWJ, Tamai M, Toes REM, van der Woude D. van Wesemael TJ, et al. Among authors: huizinga twj. Ann Rheum Dis. 2024 Jan 11;83(2):267-270. doi: 10.1136/ard-2023-224553. Ann Rheum Dis. 2024. PMID: 37788903 No abstract available.
Anti-carbamylated protein antibodies in systemic sclerosis.
Liem SIE, Hoekstra EM, Levarht EWN, Dorjee AL, Scherer HU, Toes REM, Huizinga TWJ, de Vries-Bouwstra JK, Fehres CM. Liem SIE, et al. Among authors: huizinga twj. Arthritis Res Ther. 2023 Jul 21;25(1):123. doi: 10.1186/s13075-023-03099-3. Arthritis Res Ther. 2023. PMID: 37480150 Free PMC article.
Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies.
Bitoun S, Hässler S, Ternant D, Szely N, Gleizes A, Richez C, Soubrier M, Avouac J, Brocq O, Sellam J, de Vries N, Huizinga TWJ, Jury EC, Manson JJ, Mauri C, Matucci A, Hacein Bey Abina S, Mulleman D, Pallardy M, Broët P, Mariette X; ABIRISK Consortium. Bitoun S, et al. Among authors: huizinga twj. JAMA Netw Open. 2023 Jul 3;6(7):e2323098. doi: 10.1001/jamanetworkopen.2023.23098. JAMA Netw Open. 2023. PMID: 37436748 Free PMC article.
Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation: a subanalysis after 8 years treat-to-target in the BeSt-trial.
van der Pol JA, Akdemir G, van den Broek M, Dirven L, Kerstens PJSM, Lems WF, Markusse IM, Huizinga TWJ, Allaart CF. van der Pol JA, et al. Among authors: huizinga twj. RMD Open. 2023 Apr;9(2):e002995. doi: 10.1136/rmdopen-2023-002995. RMD Open. 2023. PMID: 37185308 Free PMC article. Clinical Trial.
751 results